110 Years. 110 Stories. 110 Reasons to Raise Awareness for GBS
Annexon Biosciences partnered with GBS|CIDP Foundation International to launch the 'GBS: 110 Years, 110 Stories' campaign, aimed at raising awareness for Guillain-Barré syndrome and CIDP. The initiative will feature 110 patient stories to highlight the need for advancements in care for these rare autoimmune disorders affecting the peripheral nerves.
Key figures
- Gbs incidence
- 2 people in every 100,000
- Cidp prevalence
- 9 in 100,000
- Target patient population
- nearly 10 million
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.